RNU6ATAC13P

Across TCGA pan-cancer cohorts, RNU6ATAC13P RNA is linked to patient survival in 3 of 34 cancer types, making it the most broadly survival-associated RNU6ATAC13P data layer.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher RNU6ATAC13P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU6ATAC13P expression acts as an unfavorable survival marker.

HNSC, STAD, and ESCA are the cancer types where RNU6ATAC13P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	OS	Tertile	All	0.201	0.688	.014	108	view →
STAD	OS	Tertile	IV	0.052	0.496	<.001	36	view →
ESCA	OS	Tertile	All	0.198	0.872	.003	36	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

RNU6ATAC13P–HNSC (OS)

Open the HNSC breakdown →